Interleukin-15 as a potential regulator of the innate immune response

Brazilian Journal of Medical and Biological Research

Volumn 31, Issue 1, 1998, Pages 1-9

  Carson, W ^a   Caligiuri, M A ^a,b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Gamma interferon; Innate immunity; Interleukin 12; Interleukin 15; Natural killer cell

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 2 RECEPTOR;

B LYMPHOCYTE; CELLULAR IMMUNITY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; NATURAL KILLER CELL; REVIEW; T LYMPHOCYTE;

B-LYMPHOCYTES; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-15; KILLER CELLS, NATURAL; RECEPTORS, INTERLEUKIN-2; T-LYMPHOCYTES;

EID: 0031615612     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1998000100001     Document Type: Article

References (26)

1. Grabstein KH, Eisenman J, Shanebeck K, Rauch C, Srinivasan S, Fung V, Beers C, Richardson J, Schoenborn MA, Ahdieh M, Johnson L, Alderson MR, Watson JD, Anderson DM & Giri JG (1994). Cloning of a T cell growth factor that interacts with the ß chain of the interleukin-2 receptor. Science, 264: 965-968.
2. Tagaya Y, Bamford RN, DeFilippis AP & Waldmann TA (1996). IL-15: A pleiotropic cytokine with diverse receptor/signaling pathways whose expression is controlled at multiple levels. Immunity, 4: 329-336.
3. Anderson DM, Johnson L, Glaccum MB, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Kirstein MN, Shapiro DN, Morris SW, Grabstein K & Cosman D (1995). Chromosomal assignment and genomic structure of IL15. Genomics, 25: 701-706.
4. Carson WE, Ross ME, Baiocchi RA, Marien MJ, Boiani M, Grabstein K & Caligiuri MA (1995). Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. Journal of Clinical Investigation, 96: 2578-2582.
5. Mrozek E, Anderson P & Caligiuri MA (1996). The role of interleukin 15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells. Blood, 87: 2632-2640.
6. Giri JG, Anderson DM, Kumaki S, Park LS, Grabstein K & Cosman D (1995). IL-15, a novel T cell growth factor that shares activities and receptor components with IL-2. Journal of Leukocyte Biology, 57: 763-766.
7. Gin JG, Ahdieh M, Eisenman J, Shanebeck K, Grabstein K, Park LS, Cosman D & Anderson D (1994). Utilization of the ß and γ chains of the IL-2 receptor by the novel cytokine IL-15. EMBO Journal, 13: 2822-2830.
8. Giri JG, Kumaki S, Ahdieh M, Friend DJ, Loomis A, Shanebeck K, Dubose R, Cosman D, Park LS & Anderson DM (1995). Identification and cloning of a novel IL-15 binding protein that is structurally related to the α chain of the IL-2 receptor. EMBO Journal, 14: 3654-3663.
9. Anderson D, Satoru K, Ahdieh M, Bertles J, Tometsko M, Loomis L, Giri J, Copeland NG, Gilbert DJ, Jenkins NA, Valentine V, Shapiro DN, Morris SW, Park LS & Cosman D (1995). Functional characterization of the human interleukin-15 receptor α chain and close linkage of IL15RA and IL2RA genes. Journal of Biological Chemistry, 270: 29862-29869.
10. Carson WE, Lindemann MJ, Grabstein K & Caligiuri MA (1997). A potential role of interleukin-15 in the regulation of human natural killer cell survival. Journal of Clinical Investigation, 99: 937-943.
11. Lin J-X, Migone T-S, Tsang M, Freidmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Meitz J, John S & Leonard WJ (1995). The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity, 2: 331-339.
12. Taniguchi T (1995). Cytokine signaling through nonreceptor protein kinases. Science, 268: 251-255.
13. Mori A, Suko M, Kaminuma O, Inoue S, Ohmura T, Nishizaki Y, Nagahori T, Asakura Y, Hoshino A, Okumura Y, Sato G, Ito K & Okudaira H (1996). IL-15 promotes cytokine production of human T helper cells. Journal of Immunology, 156: 2400-2405.
14. c chains of the IL-2 receptor. Journal of Investigative Dermatology, 105: 837-843.
15. Wilkinson PC & Liew FY (1995). Chemo-attraction of human blood T lymphocytes by interleukin-15. Journal of Experimental Medicine, 181: 1255-1259.
16. Armitage RJ, Macduff BM, Eisenman J, Paxton R & Grabstein K (1995). IL-15 has stimulatory activity for the induction of B cell proliferation and differentiation. Journal of Immunology, 154: 483-490.
17. Smith KA (1993). Lowest dose interleukin-2 immunotherapy. Blood, 81: 1414-1423.
18. Smith KA (1988). Interleukin 2: Inception, impact, and implications. Science, 240: 1169-1176.
19. Robertson RJ & Ritz J (1990). Biology and clinical relevance of human natural killer cells. Blood, 76: 2421-2438.
20. Carson WE, Giri JG, Lindemann MJ, Linett ML, Ahdieh M, Anderson D, Eisenmann J, Grabstein K & Caligiuri MA (1994). Interleukin-15 is a novel cytokine which activates human natural killer cells via components of the interleukin-2 receptor. Journal of Experimental Medicine, 180: 1395-1403.
21. Biron CA & Gazzinelli RT (1995). Effects of IL-12 on immune responses to microbial infections: A key mediator in regulating disease outcome. Current Opinion in Immunology, 7: 485-496.
22. Bancroft GJ (1993). The role of natural killer cells in innate resistance to infection. Current Opinion in Immunology, 4: 503-510.
23. Tripp CS, Wolf SF & Unanue ER (1993). Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proceedings of the National Academy of Sciences, USA, 90: 3725-3729.
24. Gazzinelli RT, Hieny S, Wynn TA, Wolf S & Sher A (1993). Interleukin 12 is required for the T-lymphocyte-independent induction of interferon γ by an intracellular parasite and induces resistance in T-cell-deficient hosts. Proceedings of the National Academy of Sciences, USA, 90: 6115-6119.
25. Hunter CA, Subauste CS, Vancleave VH & Remington JS (1994). Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice. Regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infection and Immunity, 62: 2818-2824.
26. Sharma SD, Hofflin JM & Remington JS (1985). In vivo recombinant interleukin-2 administration enhances survival against a lethal challenge with Toxoplasma gondii. Journal of Immunology, 135: 4160-4163.